Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis

Carcinogenesis

Volumn 24, Issue 6, 2003, Pages 1067-1075

  Shimada, Keiji ^a   Nakamura, Mitsutoshi ^a   Ishida, Eiwa ^a   Kishi, Munehiro ^a   Konishi, Noboru ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; ANDROSTANOLONE; ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PACLITAXEL; PROTEIN BCL 2; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; TESTOSTERONE; TRANSCRIPTION FACTOR AP 1;

AMINO TERMINAL SEQUENCE; APOPTOSIS; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ESTROGEN METABOLISM; GENE INDUCTION; HUMAN; HUMAN CELL; METABOLITE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0038011249     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgg058     Document Type: Review

References (61)

1. Abate-Shen,C. and Shen,M.M. (2000) Molecular genetics of prostate cancer. Genes Dev., 14, 2410-2434.
2. Shen,J.C., Wang,T.T., Chang,S. and Hursting,S.D. (1999) Mechanistic studies of the effects of the retinoid N-(4-hydroxyphenyl)retinamide on prostate cancer cell growth and apoptosis. Mol. Carcinogen., 24, 160-168.
3. Shimada,K., Nakamura,M., Ishida,E., Kishi,M., Yonehara,S. and Konishi,N. (2002) Contributions of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cells. Mol. Carcinogen., 35, 127-137.
4. Pollard,M., Luckert,P.H. and Sporn,M.B. (1991) Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide. Cancer Res., 51, 3610-3611.
5. Kumar,A.P., Garcia,G.E. and Slaga,T.J. (2001) 2-Methoxyestradiol blocks cell-cycle progression at G(2)/M phase and inhibits growth of human prostate cancer cells. Mol. Carcinogen., 31, 111-124.
6. Mukhopadhyay,T. and Roth,J.A. (1997) Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol. Oncogene, 14, 379-384.
7. Schumacher,G., Kataoka,M., Roth,J.A. and Mukhopadhyay,T. (1999) Potent antitumor activity of 2-methoxyestradiol in human pancreatic cancer cell lines. Clin. Cancer Res., 5, 493-499.
8. Martinez,L.A., Yang,J., Vazquez,E.S., Rodriguez-Vargas Mdel,C., Olive,M., Hsieh,J.T., Logothetis,C.J. and Navone,N.M. (2002) p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cells. Carcinogenesis, 23, 1289-1296.
9. Klauber,N., Parangi,S., Flynn,E., Hamel,E. and D'Amato,R.J. (1997) Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res., 57, 81-86.
10. Maran,A., Zhang,M., Kennedy,A.M., Sibonga,J.D., Rickard,D.J., Spelsberg,T.C. and Turner,R.T. (2002) 2-Methoxyestradiol induces interferon gene expression and apoptosis in osteosarcoma cells. Bone, 30, 393-398.
11. Chauhan,D., Catley,L., Hideshima,T. et al. (2002) 2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells. Blood, 100, 2187-2194.
12. 2/M arrest and apoptosis in prostate cancer. Biochem. Biophys. Res. Commun., 285, 1259-1266.
13. Bu,S., Blaukat,A., Fu,X., Heldin,N.E. and Landstrom,M. (2002) Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells. FEBS Lett., 531, 141-151.
14. Bonkhoff,H., Fixemer,T., Hunsicker,T. and Remberger,K. (2000) Estrogen receptor gene expression and its relation to the estrogen-inducible HSP27 heat shock protein in hormone refractory prostate cancer. Prostate, 45, 36-41.
15. Lambert,C., Thews,O., Biesalski,H.K., Vaupel,P., Kelleher,D.K. and Frank,J. (2002) 2-Methoxyestradiol enhances reactive oxygen species formation and increases the efficacy of oxygen radical generating tumor treatment. Eur. J. Med. Res., 7, 404-414.
16. Wood,L., Leese,M.R., Leblond,B., Woo,L.W., Ganeshapillai,D., Purohit,A., Reed,M.J., Potter,B.V. and Packham,G. (2001) Inhibition of superoxide dismutase by 2-methoxyoestradiol analogues and oestrogen derivatives: structure-activity relationships. Anticancer Drug Res., 16, 209-215.
17. Lin,H.L., Liu,T.Y., Wu,C.W. and Chi,C.W. (2001) 2-Methoxyestradiol-induced caspase-3 activation and apoptosis occurs through G(2)/M arrest dependent and independent pathways in gastric carcinoma cells. Cancer, 92, 500-509.
18. Mukhopadhyay,T. and Roth,J.A. (1998) Superinduction of wild-type p53 protein after 2-methoxyestradiol treatment of Ad5p53-transduced cells induces tumor cell apoptosis. Oncogene, 17, 241-246.
19. Carothers,A.M., Hughes,S.A., Ortega,D. and Bertagnolli,M.M. (2002) 2-Methoxyestradiol induces p53-associated apoptosis of colorectal cancer cells. Cancer Lett., 187, 77-86.
20. Kimura,K., Bowen,C., Spiegel,S. and Gelmann,E.P. (1999) Tumor necrosis factor-alpha sensitizes prostate cancer cells to gamma-irradiation-induced apoptosis. Cancer Res., 59, 1606-1614.
21. Leith,J.T. (1994) In vitro radiation sensitivity of the LNCaP prostatic tumor cell line. Prostate, 24, 119-124.
22. Miyashita,T. and Reed,J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299.
23. Kern,S.E., Pietenpol,J.A., Thiagalingam,S., Seymour,A., Kinzler,K.W. and Vogelstein,B. (1992) Oncogenic forms of p53 inhibit p53-regulated gene expression. Science, 256, 827-830.
24. Karin,M. and Ben-Neriah,Y. (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol., 18, 621-663.
25. de Moissac,D., Zheng,H. and Kirshenbaum,L.A. (1999) Linkage of the BH4 domain of Bcl-2 and the nuclear factor kappaB signaling pathway for suppression of apoptosis. J. Biol. Chem., 274, 29505-29509.
26. Zhang,L.H., Youn,H.D. and Liu,J.O. (2001) Inhibition of cell cycle progression by the novel cyclophilin ligand sanglifehrin A is mediated through the NFkappa B-dependent activation of p53. J. Biol. Chem., 276, 43534-43540.
27. Kim,S.J., Hwang,S.G., Shin,D.Y., Kang,S.S. and Chun,J.S. (2002) p38 kinase regulates nitric oxide-induced apoptosis of articular chondrocytes by accumulating p53 via NFkappaB-dependent transcription and stabilization by serine 15 phosphorylation. J. Biol. Chem., 277, 33501-33508.
28. Hellin,A.C., Calmant,P., Gielen,J., Bours,V. and Merville,M.P. (1998) Nuclear factor-kappaB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drug. Oncogene, 16, 1187-1195.
29. Ryan,K.M., Ernst,M.K., Rice,N.R. and Vousden,K.H. (2000) Role of NF-kappaB in p53-mediated programmed cell death. Nature, 404, 892-897.
30. MacKeigan,J.P., Collins,T.S. and Ting,J.P. (2000) MEK inhibition enhances paclitaxel-induced tumor apoptosis. J. Biol. Chem., 275, 38953-38956.
31. Gupta,K., Kshirsagar,S., Li,W., Gui,L., Ramakrishnan,S., Gupta,P., Law,P.Y. and Hebbel,R.P. (1999) VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp. Cell. Res., 247, 495-504.
32. Davis,R.J. (2000) Signal transduction by the JNK group of MAP kinases. Cell, 103, 239-252.
33. Wilkinson,M.G. and Millar,J.B. (1998) SAPKs and transcription factors do the nucleocytoplasmic tango. Genes Dev., 12, 1391-1397.
34. Keller,D., Zeng,X., Li,X., Kapoor,M., Iordanov,M.S., Taya,Y., Lozano,G., Magun,B. and Lu,H. (1999) The p38MAPK inhibitor SB203580 alleviates ultraviolet-induced phosphorylation at serine 389 but not serine 15 and activation of p53. Biochem. Biophys. Res. Commun., 261, 464-471.
35. Kwon,Y.W., Ueda,S., Ueno,M., Yodoi,J. and Masutani,H. (2002) Mechanism of p53-dependent apoptosis induced by 3-methylcholanthrene: involvement of p53 phosphorylation and p38 MAPK. J. Biol. Chem., 277, 1837-1844.
36. Haldar,S., Basu,A. and Croce,C.M. (1997) Bcl2 is the guardian of microtubule integrity. Cancer Res., 57, 229-233.
37. Shimada,K., Nakamura,M., Ishida,E., Kishi,M., Yonehara,S. and Konishi,N. (2002) Phosphorylation of Fas-associated death domain contributes to enhancement of etoposide-induced apoptosis in prostate cancer cells. Jpn. J. Cancer Res., 93, 1164-1174.
38. Takeshita,A., Watanabe,A., Takada,Y. and Hanazawa,S. (2000) Selective stimulation by ceramide of the expression of the alpha isoform of retinoic acid and retinoid X receptors in osteoblastic cells. A role of sphingosine 1-phosphate-mediated AP-1 in the ligand-dependent transcriptional activity of these receptors. J. Biol. Chem., 275, 32220-32226.
39. Kondo,T., Matsuda,T., Kitano,T., Takahashi,A., Tashima,M., Ishikura,H., Umehara,H., Domae,N., Uchiyama,T. and Okazaki,T. (2000) Role of c-jun expression increased by heat shock- and ceramide-activated caspase-3 in HL-60 cell apoptosis. Possible involvement of ceramide in heat shock-induced apoptosis. J. Biol. Chem., 275, 7668-7676.
40. Chaturvedi,M.M., Mukhopadhyay,A. and Aggarwa1,B.B. (2000) Assay for redox-sensitive transcription factor. Methods Enzymol., 319, 585-602.
41. Mukhopadhyay,A., Bueso-Ramos,C., Chatterjee,D., Pantazis,P. and Aggarwal,B.B. (2001) Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene, 20, 7597-7609.
42. 2-terminal kinase-dependent Fas activation contributes to etoposide-induced apoptosis in p53-mutated prostate cancer cells. Prostate, 55, 265-280.
43. Shimada,K., Nakamura,M., Ishida,E., Kishi,M., Yonehara,S. and Konishi,N. (2003) The requirement of c-jun for testosterone-induced sensitization to N-(4-hydroxyphenyl) retinamide-induced apoptosis. Mol. Carcinogen., 36, 115-122.
44. Attalla,H., Makela,T.P., Adlercreutz,H. and Andersson,L.C. (1996) 2-Methoxyestradiol arrests cells in mitosis without depolymerizing tubulin. Biochem. Biophys. Res. Commun., 228, 467-473.
45. Yue,T.L., Wang,X., Louden,C.S., Gupta,S., Pillarisetti,K., Gu,J.L., Hart,T.K., Lysko,P.G. and Feuerstein,G.Z. (1997) 2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: possible role for stress-activated protein kinase signaling pathway and Fas expression. Mol. Pharmacol., 51, 951-962.
46. Yu,C., Wang,S., Dent,P. and Grant,S. (2001) Sequence-dependent potentiation of paclitaxel-mediated apoptosis in human leukemia cells by inhibitors of the mitogen-activated protein kinase kinase/mitogen-activated protein kinase pathway. Mol. Pharmacol., 60, 143-154.
47. Liu,B., Fang,M., Lu,Y., Mills,G.B. and Fan,Z. (2001) Involvement of JNK-mediated pathway in EGF-mediated protection against paclitaxel-induced apoptosis in SiHa human cervical cancer cells. Br. J. Cancer, 85, 303-311.
48. MacKeigan,J.P., Collins,T.S. and Ting,J.P. (2000) MEK inhibition enhances paclitaxel-induced tumor apoptosis. J. Biol. Chem., 275, 38953-38956.
49. Subbaramaiah,K., Hart,J.C., Norton,L. and Dannenberg,A.J. (2000) Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 AND p38 mitogen-activated protein kinase pathways. J. Biol. Chem., 275, 14838-14845.
50. Zhu,J., Song,X., Lin,H.P., Young,D.C., Yan,S., Marquez,V.E. and Chen,C.S. (2002) Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents. J. Natl Cancer Inst., 94, 1745-1757.
51. Fujita,H., Koshida,K., Keller,E.T., Takahashi,Y., Yoshimito,T., Namiki,M. and Mizokami,A. (2002) Cyclooxygenase-2 promotes prostate cancer progression. Prostate, 53, 232-240.
52. 2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risks. Biochem. J., 366, 831-837.
53. Song,X., Lin,H.P., Johnson,A.J., Tseng,P.H., Yang,Y.T., Kulp,S.K. and Chen,C.S. (2002) Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells. J. Natl Cancer Inst., 94, 585-591.
54. Kirschenbaum,A., Liu,X., Yao,S. and Levine,A.C. (2001) The role of cyclooxygenase-2 in prostate cancer. Urology, 58, 127-131.
55. Kirch,H.C., Flaswinkel,S., Rumpf,H., Brockmann,D. and Esche,H. (1999) Expression of human p53 requires synergistic activatioh of transcription from the p53 promoter by AP-1, NF-kappaB and Myc/Max. Oncogene, 18, 2728-2738.
56. Beg,A.A. and Baltimore,D. (1996) An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science, 274, 782-784.
57. Grimm,S., Bauer,M.K., Baeuerle,P.A. and Schulze-Osthoff,K. (1996) Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis. J. Cell. Biol., 134, 13-23.
58. Qin,Z.H., Wang,Y., Nakai,M. and Chase,T.N. (1998) Nuclear factor-kappa B contributes to excitotoxin-induced apoptosis in rat striatum. Mol. Pharmacol., 53, 33-42.
59. MacKeigan,J.P., Taxman,D.J., Hunter,D., Earp,H.S. 3rd, Graves,L.M. and Ting,J.P. (2002) Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition. Clin. Cancer Res., 8, 2091-2099.
60. Wang,L.G., Ossowski,L. and Ferrari,A.C. (2001) Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line. Cancer Res., 61, 7544-7551.
61. Kimura,K., Markowski,M., Bowen,C. and Gelmann,E.P. (2001) Androgen blocks apoptosis of hormone-dependent prostate cancer cells. Cancer Res., 61, 5611-5618.